We are live on ! Find out more
WHWK icon

Whitehawk Therapeutics

33 hedge funds and large institutions have $26.2M invested in Whitehawk Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,225% more capital inflows, than outflows

Capital inflows: $12.3M | Capital outflows: $930K

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

240% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 5

57% more funds holding

Funds holding: 21 → 33 (+12)

18.41% more ownership

Funds ownership: 23.06% → 41.47% (+18%)

Holders
33
Holders Change
+12
Holders Change %
+57.14%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
7
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

WHWK Hedge Fund Activity: Q3 2020 in Review

33 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q3 2020, worth a combined $26.2M — up 124% from $11.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new WHWK positions and 5 closed out — a net gain of 12 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $5.53M. The largest seller was Renaissance Technologies, cutting an estimated $464K.

  • 33 institutional investors held Whitehawk Therapeutics (WHWK) as of Q3 2020, up from 21 in Q2 2020.
  • Funds reported $26.2M of Whitehawk Therapeutics stock for Q3 2020, up 124% quarter-over-quarter.
  • 17 funds opened new Whitehawk Therapeutics positions in Q3 2020 and 5 closed out, a net change of +12 holders.
  • The largest Whitehawk Therapeutics buyer in Q3 2020 was Ikarian Capital, an estimated $5.53M added.
  • The largest Whitehawk Therapeutics seller in Q3 2020 was Renaissance Technologies, an estimated $464K sold.

Based on aggregated 13F filings for Q3 2020.